scholarly journals Rapid cystic fibrosis lung-function decline and in-vitro CFTR modulation

Author(s):  
Emrah Gecili ◽  
Weiji Su ◽  
Cole Brokamp ◽  
Eleni-Rosalina Andrinopoulou ◽  
Francis J. LaRosa III ◽  
...  
PLoS ONE ◽  
2016 ◽  
Vol 11 (8) ◽  
pp. e0160726 ◽  
Author(s):  
Giovanni Bacci ◽  
Patrizia Paganin ◽  
Loredana Lopez ◽  
Chiara Vanni ◽  
Claudia Dalmastri ◽  
...  

PLoS ONE ◽  
2016 ◽  
Vol 11 (6) ◽  
pp. e0156807 ◽  
Author(s):  
Giovanni Bacci ◽  
Patrizia Paganin ◽  
Loredana Lopez ◽  
Chiara Vanni ◽  
Claudia Dalmastri ◽  
...  

2020 ◽  
Vol 19 (4) ◽  
pp. 527-533
Author(s):  
Elliott C. Dasenbrook ◽  
Aliza K. Fink ◽  
Michael S. Schechter ◽  
Don B. Sanders ◽  
Stefanie J. Millar ◽  
...  

2018 ◽  
Author(s):  
Jessie E. Scott ◽  
Kewei Li ◽  
Laura M. Filkins ◽  
Bin Zhu ◽  
Sherry L. Kuchma ◽  
...  

AbstractCystic Fibrosis (CF) is a genetic disease that causes patients to accumulate thick, dehydrated mucus in the lung and develop chronic, polymicrobial infections due to reduced mucociliary clearance. These chronic polymicrobial infections and subsequent decline in lung function are significant factors in the morbidity and mortality of CF.Pseudomonas aeruginosaandStreptococcusspp. are among the most prevalent organisms in the CF lung; the presence ofP. aeruginosacorrelates with lung function decline and theStreptococcus millerigroup (SMG), a subgroup of the viridans streptococci, is associated with exacerbations in patients with CF. Here we characterize the interspecies interactions that occur between these two genera. We demonstrated that multipleP. aeruginosalaboratory strains and clinical CF isolates promote the growth of multiple SMG strains and oral streptococci in anin vitrococulture system. We investigated the mechanism by whichP. aeruginosaenhances growth of streptococci by screening for mutants ofP. aeruginosaPA14 unable to enhanceStreptococcusgrowth, and we identified theP. aeruginosa pqsL::TnMmutant, which failed to promote growth ofS. constellatusandS. sanguinis. Characterization of theP. aeruginosaΔpqsLmutant revealed that this strain cannot promoteStreptococcusgrowth. Our genetic data and growth studies support a model whereby theP. aeruginosaΔpqsLmutant overproduces siderophores, and thus likely outcompetesStreptococcus sanguinisfor limited iron. We propose a model whereby competition for iron represents one important means of interaction betweenP. aeruginosaandStreptococcusspp.ImportanceCystic fibrosis (CF) lung infections are increasingly recognized for their polymicrobial nature. These polymicrobial infections may alter the biology of the organisms involved in CF-related infections, leading to changes in growth, virulence and/or antibiotic tolerance, and could thereby affect patient health and response to treatment. In this study, we demonstrate interactions betweenP. aeruginosaand streptococci using a coculture model, and show that one interaction between these microbes is likely competition for iron. Thus, these data indicate that one CF pathogen may influence the growth of another and add to our limited knowledge of polymicrobial interactions in the CF airway.


Pathogens ◽  
2021 ◽  
Vol 10 (6) ◽  
pp. 703
Author(s):  
Kayla Fantone ◽  
Samantha L. Tucker ◽  
Arthur Miller ◽  
Ruchi Yadav ◽  
Eryn E. Bernardy ◽  
...  

Cystic fibrosis (CF) airway disease is characterized by chronic microbial infections and infiltration of inflammatory polymorphonuclear (PMN) granulocytes. Staphylococcus aureus (S. aureus) is a major lung pathogen in CF that persists despite the presence of PMNs and has been associated with CF lung function decline. While PMNs represent the main mechanism of the immune system to kill S. aureus, it remains largely unknown why PMNs fail to eliminate S. aureus in CF. The goal of this study was to observe how the CF airway environment affects S. aureus killing by PMNs. PMNs were isolated from the blood of healthy volunteers and CF patients. Clinical isolates of S. aureus were obtained from the airways of CF patients. The results show that PMNs from healthy volunteers were able to kill all CF isolates and laboratory strains of S. aureus tested in vitro. The extent of killing varied among strains. When PMNs were pretreated with supernatants of CF sputum, S. aureus killing was significantly inhibited suggesting that the CF airway environment compromises PMN antibacterial functions. CF blood PMNs were capable of killing S. aureus. Although bacterial killing was inhibited with CF sputum, PMN binding and phagocytosis of S. aureus was not diminished. The S. aureus-induced respiratory burst and neutrophil extracellular trap release from PMNs also remained uninhibited by CF sputum. In summary, our data demonstrate that the CF airway environment limits killing of S. aureus by PMNs and provides a new in vitro experimental model to study this phenomenon and its mechanism.


2013 ◽  
Vol 49 (9) ◽  
pp. 873-877 ◽  
Author(s):  
Liam Welsh ◽  
Colin F. Robertson ◽  
Sarath C. Ranganathan

2016 ◽  
Vol 15 ◽  
pp. S117-S118
Author(s):  
F. Ferro ◽  
F. Freitas ◽  
C. Lopes ◽  
R. Costa ◽  
A. Pinto ◽  
...  

2021 ◽  
Vol 22 (21) ◽  
pp. 12050
Author(s):  
Cynthia B. Silveira ◽  
Ana G. Cobián-Güemes ◽  
Carla Uranga ◽  
Jonathon L. Baker ◽  
Anna Edlund ◽  
...  

Ecological networking and in vitro studies predict that anaerobic, mucus-degrading bacteria are keystone species in cystic fibrosis (CF) microbiomes. The metabolic byproducts from these bacteria facilitate the colonization and growth of CF pathogens like Pseudomonas aeruginosa. Here, a multi-omics study informed the control of putative anaerobic keystone species during a transition in antibiotic therapy of a CF patient. A quantitative metagenomics approach combining sequence data with epifluorescence microscopy showed that during periods of rapid lung function loss, the patient’s lung microbiome was dominated by the anaerobic, mucus-degrading bacteria belonging to Streptococcus, Veillonella, and Prevotella genera. Untargeted metabolomics and community cultures identified high rates of fermentation in these sputa, with the accumulation of lactic acid, citric acid, and acetic acid. P. aeruginosa utilized these fermentation products for growth, as indicated by quantitative transcriptomics data. Transcription levels of P. aeruginosa genes for the utilization of fermentation products were proportional to the abundance of anaerobic bacteria. Clindamycin therapy targeting Gram-positive anaerobes rapidly suppressed anaerobic bacteria and the accumulation of fermentation products. Clindamycin also lowered the abundance and transcription of P. aeruginosa, even though this patient’s strain was resistant to this antibiotic. The treatment stabilized the patient’s lung function and improved respiratory health for two months, lengthening by a factor of four the between-hospitalization time for this patient. Killing anaerobes indirectly limited the growth of P. aeruginosa by disrupting the cross-feeding of fermentation products. This case study supports the hypothesis that facultative anaerobes operated as keystone species in this CF microbiome. Personalized multi-omics may become a viable approach for routine clinical diagnostics in the future, providing critical information to inform treatment decisions.


Sign in / Sign up

Export Citation Format

Share Document